The biosurgical products company has received $10m from investors including MedEdge.
US-based biosurgical products producer Abryx has closed a $10m funding round that featured medical device company MedEdge, according to FinSMEs.
The round also included unnamed members of Abryx’s executive team, Canaan Partners and BB Biotech Ventures.
Founded in 2013, Abryx develops and manufactures therapeutic devices to be used during surgery. The company has licensed an adhesive technology for soft tissue applications from Bezwada Biomedical concurrent to its funding round.
The two partners previously signed an agreement for a similar product…
